Adaptive Partial Drug Approval
Currently the FDA requires that drug companies conduct 3 phases in order to secure the approval of a pharmaceutical. These are: Phase I. These are smaller (20-80 participants), clinical trials which determine a drug’s safety and pharmacologic properties among healthy volunteers. Phase II. This phase tests a drug’s efficacy and optimal dosage. Typically 100-300 individuals…